Growth hormone and insulin-like growth factor I augment Escherichia coli-killing activity of murine peritoneal exudative cells

Shock

Volumn 6, Issue 5, 1996, Pages 345-350

  Inoue, Tomomi ^a   Saito, Hideaki ^a   Hashiguchi, Yojiro ^a   Fukatsu, Kazuhiko ^a   Inaba, Tsuyoshi ^a   Lin, Ming Tsan ^a   Han, Ilsoo ^a   Furukawa, Satoshi ^a   Muto, Tetsuichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN; CYTOKINE; GROWTH HORMONE; PROTEIN HYDROLYSATE; SOMATOMEDIN C; TRYPTICASE SOY BROTH; TRYPTICASE-SOY BROTH;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; CYTOLOGY; DRUG EFFECT; ESCHERICHIA COLI; EXUDATE; FEMALE; METABOLISM; MICROBIOLOGY; MOUSE; PERITONEAL CAVITY; PHYSIOLOGY; SERUM BACTERICIDAL ACTIVITY;

ANIMALS; BLOOD BACTERICIDAL ACTIVITY; CASEINS; CYTOKINES; ESCHERICHIA COLI; EXUDATES AND TRANSUDATES; FEMALE; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, INBRED BALB C; PERITONEAL CAVITY; PROTEIN HYDROLYSATES;

EID: 0030280347     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199611000-00008     Document Type: Article

References (35)

1. Maddaus MA, Ahrenholz D, Simmons RL: The biology of peritonitis and implications for treatment. Surg Clin North Am 68:431-443, 1988.
2. Voerman HJ, Strack van Schijndel RJ, de Boer H, van der Veen EA, Thijs LG: Growth hormone: secretion and administration in catabolic adult patients, with emphasis on the critically ill patient. Neth J Med 41:229-244, 1992.
3. Chwals WJ, Bistrian BR: Role of exogenous growth hormone and insulin-like growth factor I in malnutrition and acute metabolic stress: A hypothesis. Crit Care Med 19:1317-1322, 1991.
4. Kelley KW: The role of growth hormone in modulation of the immune response. Ann NY Acad Sci 594:95-103, 1990.
5. Arkins S, Dantzer R, Kelley KW: Somatolactogens, somatomedins, and immunity. J Dairy Sci 76:2437-2450, 1993.
6. Wiedermann CJ, Reinisch N, Kahler C, Braunsteiner H: Regulation of myeloid phagocyte development and function by growth hormone: A review. J Pediatr Endocrinol 6:85-91, 1993.
7. Saito H, Inoue T, Fukatsu K, Lin MT, Inaba T, Fukushima R, Muto T: Growth hormone and the immune response to bacterial infection. Horm Res 45:50-54, 1996.
8. Edwards CK III, Ghiasuddin SM, Schepper JM, Yunger LM, Kelley KW: A newly defined property of somatotropin: Priming of macrophages for production of superoxide anion. Science 239:769-771, 1988.
9. Edwards CK III, Arkins S, Yunger LM, Blum A, Dantzer R, Kelley KW: The macrophage-activating properties of growth hormone. Cell Mol Neurobiol 12:499-510, 1992.
10. Fu YK, Arkins S, Wang BS, Kelley KW: A novel role of growth hormone and insulin-like growth factor-I: Priming neutrophils for superoxide anion secretion. J Immunol 146:1602-1608, 1991.
11. Edwards CK III, Lorence RM, Dunham DM, et al: Hypophysectomy inhibits the synthesis of tumor necrosis factor a by rat macrophages: Partial restoration by exogenous growth hormone or interferon γ. Endocrinology 128:989-996, 1991.
12. Edwards CK III, Yunger LM, Lorence RM, Dantzer R, Kelley KW: The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. Proc Natl Acad Sci USA 88:2274-2277, 1991.
13. Edwards CK III, Ghiasuddin SM, Yunger LM, et al: In vivo administration of recombinant growth hormone or gamma interferon activates macrophages: Enhanced resistance to experimental Salmonella typhimurium infection is correlated with generation of reactive oxygen intermediates. Infect Immun 60:2514-2521, 1992.
14. Fu YK, Arkins S, Li YM, Dantzer R, Kelley KW: Reduction in superoxide anion secretion and bactericidal activity of neutrophils from aged rats: Reversal by the combination of gamma interferon and growth hormone. Infect Immun 62:1-8, 1994.
15. Inoue T, Saito H, Fukushima R, et al: Growth hormone and insulinlike growth factor I enhance host defense in a murine sepsis model. Arch Surg 130:1115-1122, 1995.
16. Tyler JW, Cullor JS, Osburn BI, Parker K: Age-related variations in serum concentrations of the third component of complement in swine. Am J Vet Res 49:1104-1106, 1988.
17. Dunn DL, Barke RA, Knight NB, Humphrey EW, Simmons RL: Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity. Infect Immun 49: 257-264, 1985.
18. Bendtzen K: Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. Immunol Lett 19:183-191, 1988.
19. Rasmussen Busund LT, Konopski Z, Øian P, Seljelid R: Killing of Escherichia coli by mononuclear phagocytes and neutrophils stimulated in vitro with β-1, 3-D-polyglucose derivatives. Microbiol Immunol 36:1173-1188, 1992.
20. Yoshida A, Ishioka C, Kimata H, Mikawa H: Recombinant human growth hormone stimulates B cell immunoglobulin synthesis and proliferation in serum-free medium. Acta Endocrinol Copenh 126:524-529, 1992.
21. Robbins K, McCabe S, Scheiner T, Strasser J, Clark R, Jardieu P: Immunological effects of insulin-like growth factor-I-enhancement of immunoglobulin synthesis. Clin Exp Immunol 95:337-342, 1994.
22. Lanzi R, Tannenbaum GS: Time course and mechanism of growth hormone's negative feedback effect on its own spontaneous release. Endocrinology 130:780-788, 1992.
23. Inaba T, Saito H, Fukushima R, et al: Effects of growth hormone and insulin-like growth factor 1 (IGF-I) treatments on the nitrogen metabolism and hepatic IGF-1-messenger RNA expression in postoperative parenterally fed rats. J Parenter Enteral Nutr 20:325-331, 1996.
24. 2. J Immunol 154:1909-1918, 1995.
25. Zhao X, McBride BW, Trouten Radford LM, Burton JH: Effects of insulin-like growth factor-I and its analogues on bovine hydrogen peroxide release by neutrophils and blastogenesis by mononuclear cells. J Endocrinol 139:259-265, 1993.
26. Bjerknes R, Aarskog D: Priming of human polymorphonuclear neutrophilic leukocytes by insulin-like growth factor I: Increased phagocytic capacity, complement receptor expression, degranulation, and oxidative burst. J Clin Endocrinol Metab 80:1948-1955, 1995.
27. - by human neutrophils via a complement iC3b/Mac-1 interaction. Biol Signals 2:126-135, 1993.
28. Simms HH, D'Amico R: Granulocyte colony-stimulating factor reverses septic shock-induced polymorphonuclear leukocyte dysfunction. Surgery 115:85-93, 1994.
29. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A: Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012-2020, 1992.
30. Marcus R, Butterfield G, Holloway L, et al: Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 70:519-527, 1990.
31. Dahn MS, Mitchell RA, Smith S, Lange MP, Whitcomb MP, Kirkpatrick JR: Altered immunologic function and nitrogen metabolism associated with depression of plasma growth hormone. J Parenter Enteral Nutr 8:690-694, 1984.
32. Wiedermann CJ, Niedermuhlbichler M, Beimpold H, Braunsteiner H: In vitro activation of neutrophils of the aged by recombinant human growth hormone. J Infect Dis 164:1017-1020, 1991.
33. Frayn KN, Price DA, Maycock PF, Carroll SM: Plasma somatomedin activity after injury in man and its relationship to other hormonal and metabolic changes. Clin Endocrinol 20:179-187, 1984.
34. Voerman HJ, Johan Groeneveld AB, de Boer H, et al: Time course and variability of the endocrine and metabolic response to severe sepsis. Surgery 114:951-959, 1993.
35. Florini JR, Prinz PN, Vitiello MV, Hintz RL: Somatomedin-C levels in healthy young and old men: Relationship to peak and 24-hour integrated levels of growth hormone. J Gerontol 40:2-7, 1985.